Front Immunol, 2023, 14:1232924

Removal of natural anti-αGal antibodies elicits protective immunity against Gram-negative bacterial infections

Antibody-dependent enhancement (ADE) of bacterial infections occurs when blocking or inhibitory antibodies facilitate the infectivity of pathogens. In humans, antibodies involved in ADE of bacterial infections may include those naturally produced against Galα1-3Galβ1-4GlcNAcβ (αGal). Here, we investigate whether eliminating circulating anti-αGal antibodies using a soluble αGal glycopolymer confers protection against Gram-negative bacterial infections. We demonstrated that the intra-corporeal removal of anti-αGal antibodies in α1,3-galactosyltransferase knockout (GalT-KO) mice was associated with protection against mortality from Gram-negative sepsis after cecal ligation and puncture (CLP). The improved survival of GalT-KO mice was associated with an increased killing capacity of serum against isolated after CLP and reduced binding of IgG1 and IgG3 to the bacteria. Additionally, inhibition of anti-αGal antibodies from human serum increases the bactericidal killing of O86:B7 and multidrug-resistant and In the case of O86:B7, there was also an improvement in bacteria opsonophagocytosis by macrophages. Both lytic mechanisms were related to a decreased binding of IgG2 to the bacteria. Our results show that protective immunity against Gram-negative bacterial pathogens can be elicited, and infectious diseases caused by these bacteria can be prevented by removing natural anti-αGal antibodies.

Olivera-Ardid S, Bello-Gil D, Perez-Cruz M, Costa C, Camoez M, Dominguez MA, Ferrero-Alves Y, Vaquero JM, Khasbiullina N, Shilova NV, Bovin NV, Mañez R

IBCH: 10864
Ссылка на статью в журнале: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1232924/full
Кол-во цитирований на 12.2024: 2
Данные статьи проверены модераторами 2023-10-07

Список научных проектов, где отмечена публикация

  1. PI13/01098. . Сommercial.
  2. 2018 DI 021. . Сommercial.
  3. 603049. . Сommercial.
  4. Anti-glycan natural antibodies (January 6, 2014 — December 31, 2016). Bovin N.V.. Grant, RSF.